File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL

Conference Paper: Evaluation of human epididymal secretory protein E4 (HE4) for monitoring for ovarian cancer recurrence

TitleEvaluation of human epididymal secretory protein E4 (HE4) for monitoring for ovarian cancer recurrence
Authors
Issue Date2010
PublisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.ijgc.net/
Citation
The 13th Biennial Meeting of the International Gynaecological Cancer Society (IGCS 2010), Prague, the Czech Republic, 23-26 October 2010. In International Journal of Gynecological Cancer, 2010, v. 20 suppl. 2 How to Cite?
AbstractINTRODUCTION: Serum HE4, a new biomarker for ovarian cancer, was shown to have a better sensitivity for detecting ovarian cancer compared to Ca 125, especially in early disease. In this study, we measured the HE4 levels in patients who had relapsed ovarian cancer in an attempt to elucidate its role in disease monitoring and recurrence detection. METHODS: HE4 levels were measured at pre-treatment, immediately post ...
Persistent Identifierhttp://hdl.handle.net/10722/136276
ISSN
2015 Impact Factor: 2.116
2015 SCImago Journal Rankings: 0.830

 

DC FieldValueLanguage
dc.contributor.authorChan, Ken_US
dc.contributor.authorTam, KFen_US
dc.contributor.authorNgan, Hen_US
dc.date.accessioned2011-07-27T02:12:10Z-
dc.date.available2011-07-27T02:12:10Z-
dc.date.issued2010en_US
dc.identifier.citationThe 13th Biennial Meeting of the International Gynaecological Cancer Society (IGCS 2010), Prague, the Czech Republic, 23-26 October 2010. In International Journal of Gynecological Cancer, 2010, v. 20 suppl. 2en_US
dc.identifier.issn1048-891X-
dc.identifier.urihttp://hdl.handle.net/10722/136276-
dc.description.abstractINTRODUCTION: Serum HE4, a new biomarker for ovarian cancer, was shown to have a better sensitivity for detecting ovarian cancer compared to Ca 125, especially in early disease. In this study, we measured the HE4 levels in patients who had relapsed ovarian cancer in an attempt to elucidate its role in disease monitoring and recurrence detection. METHODS: HE4 levels were measured at pre-treatment, immediately post ...-
dc.languageengen_US
dc.publisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.ijgc.net/-
dc.relation.ispartofInternational Journal of Gynecological Canceren_US
dc.rightsThis is a non-final version of an article published in final form in (provide complete journal citation)-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.titleEvaluation of human epididymal secretory protein E4 (HE4) for monitoring for ovarian cancer recurrenceen_US
dc.typeConference_Paperen_US
dc.identifier.emailChan, K: kklchan@hkucc.hku.hken_US
dc.identifier.emailTam, KF: tamkf@hkucc.hku.hken_US
dc.identifier.emailNgan, H: hysngan@hkucc.hku.hken_US
dc.identifier.authorityChan, K=rp00499en_US
dc.identifier.authorityNgan, H=rp00346en_US
dc.description.naturepostprint-
dc.identifier.hkuros187175en_US
dc.identifier.volume20-
dc.identifier.issuesuppl. 2-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats